| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |